The Future of Molecular Approaches to Inflammatory Bowel Disease

被引：0
|
作者：
Boyko Kabakchiev
Smita Halder
Mark S. Silverberg
机构：
[1] University of Toronto,Mount Sinai Hospital Inflammatory Bowel Disease Group, Dr Zane Cohen Digestive Diseases Clinical Research Centre
[2] Mount Sinai Hospital,Inflammatory Bowel Disease Group
[3] Joseph and Wolf Lebovic Health Complex,undefined
来源：
Molecular Diagnosis & Therapy | 2009年 / 13卷
关键词：
Inflammatory Bowel Disease; Ulcerative Colitis; Irritable Bowel Syndrome; Protein Chip; Inflammatory Bowel Disease Diagnosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Technological advances in genomics and transcriptomics have resulted in the introduction of molecular tests into the clinical arena. Despite established uses of such tests in the oncology field, their integration into the management of complex diseases has not been widely evaluated. Progress in the field of inflammatory bowel disease (IBD) genetics has been rapid in recent years, and these advances have provided more urgent impetus to investigating the role of molecular tests in IBD. This article summarizes the current state of molecular testing available for IBD, and the potential utility of such tests as research in the area widens.
引用
收藏
页码：217 / 223
页数：6
相关论文
共 50 条
12345